Global Microneedles for Drug Delivery Patent Landscape Report 2024

Global Microneedles for Drug Delivery Market Size

The global microneedles for drug delivery market was valued at USD 3.03 billion in 2023. It is expected to grow at a CAGR of 7.2% during the forecast period of 2024-2023 and attain a market value of USD 5.67 billion in 2032. The market value is impacted by the increasing use of such platforms and ongoing technological advancements in this field. There has been a significant increase in the number of patent applications associated with microneedles for drug delivery, driven by the rising prevalence of chronic illnesses including diabetes, cancer, and cardiovascular disorders which makes novel medication delivery methods like microneedles necessary.

Patent Landscape Report Coverage

The Global Microneedles For Drug Delivery Patent Landscape report includes a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for microneedles for drug delivery include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within microneedles for drug delivery technologies.

Microneedles built on a microelectromechanical system (MEMS) are a novel approach to medication administration that improves skin permeability. It causes small pores to open in the skin, which facilitates the passive diffusion of medications to cause dermal microcirculation. This phenomenon facilitates effective medication absorption. MEMS microneedles are tiny needles that typically range in size from microns to millimetres. Typically, they have dimensions of roughly 150–550 µm in length and 50–300 µm in width. Their tip diameter ranges from 1 to 80 µm, allowing them to painlessly penetrate the epidermis layer and reach the dermal tissues. Therefore, such technical innovations are impacting the patent landscape significantly.

Global Microneedles for Drug Delivery Patent Market Outlook

• The use of microneedles is increasing because of patient’s choice for less intrusive and uncomfortable drug delivery techniques and is augmenting the market size and growth rate.

• The need for simpler and more efficient drug delivery techniques is driven by the aging population, which frequently needs regular, long-term medicine.

• The pharmaceutical and biopharmaceutical companies and research institutions are actively investing the micro-needling technology for drug delivery since it allows direct administration of medications into the bloodstream or specific tissues and increases the bioavailability of pharmaceutical drugs.

Microneedles For Drug Delivery: Introduction

Micro-needling for drug delivery is a minimally invasive technique that uses tiny needles to create microchannels in the skin, enabling painless and efficient delivery of drugs, vaccines and therapeutic agents. This method improves the absorption of drugs, reduces pain, and the risk of infection and allows self-administration. There are different types of microneedles, including solid, coated, dissolvable, hollow, and hydrogel-shaped, each suitable for different applications in cosmetics and medicine. They offer a promising alternative to traditional needles, improving patient compliance and improving treatment outcomes.

The application of microneedles for drug delivery continues to evolve, driven by the use in cosmetic treatments such as antiaging and skin rejuvenation procedures. Microneedle-based products are increasingly approved by regulatory authorities, thus facilitating market growth. Microneedles offer a more comfortable and less painful alternative to traditional hypodermic needles  that improves patient compliance which is a driving factor to boost market value in the forecast period.

Microneedles for Drug Delivery Industry Growth Drivers

Increasing Prevalence of Chronic Diseases is Expected to Boost the Market Growth

The increasing prevalence of chronic diseases such as diabetes , cardiovascular disease and cancer increases the need for effective and efficient drug delivery systems. Microneedles offer a minimally invasive solution that improves patient compliance and ensures consistent drug dosing. This demand is driving innovation and the adoption of microneedling techniques in the management of long-term treatment regimens.

For instance, In November 2021, NanoPass Technologies and Aesthetic Management Partners (AMP) signed an agreement to begin commercialization of NanoPass's MicronJet® 600 aesthetic delivery device in the United States. MicronJet 600 is an intradermal injection device with three 0.6 mm hollow pyramid-shaped microneedles. It was manufactured by NanoPass Technologies using the silicon microelectromechanical system (MEMS) technology.

Increasing Demand for Minimally Invasive Techniques is Expected to Propel the Microneedles for Drug Delivery Industry Growth

The demand for minimally invasive procedures derives from patients wanting less painful and more comfortable treatment options. Microneedles meet this need by offering a painless alternative to traditional injections, reducing discomfort, and improving patient compliance. This trend is accelerating the development and adoption of micro needle techniques in various medical and cosmetic applications.

Global Microneedles for Drug Delivery Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation -

Breakup by Product

• Solid Microneedles
  • Silicon
  • Metal
  • Polymer

• Hollow Microneedles

• Dissolving Microneedles

• Hydrogel

• Coated

The report will cover the following sections in detail:

Microneedles for Drug Delivery Patent Segmentation Analysis

The breakup based on the platform includes solid, dissolving, hydrogel, coated and hollow microneedles. Microneedles for drug delivery investigations have been conducted with the chosen patent families labelled based on the product.

Coated microneedles are designed to have a drug layer on their surface that dissolves when inserted into the skin and transports the drug directly to the target tissue. This method allows precise and effective administration of the drug, which improves therapeutic efficiency and reduces pain and discomfort.

The detailed technological data will be provided for all specified segments classified in this report.

Microneedles for Drug Delivery Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for microneedles for drug delivery patents, having around 13000 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

  
China is another vital jurisdiction and is witnessing rapid growth in patent filings as it holds a major chunk of the global population. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications. Innovations like the development of novel technologies for microneedles are amongst major growth factors.

Patent Profile of Key Companies

Among the players with microneedles for drug delivery patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field.  Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Minnesota Mining and Manufacturing Company

The Minnesota Mining and Manufacturing Company, known as 3M, is a global conglomerate that specializes in various industries, including healthcare. 3M has developed innovative microneedle technology for drug delivery leveraging experience in materials science and manufacturing. The company's microneedle platforms are designed to provide painless and effective drug delivery, consistent with the company's commitment to improving patient outcomes and advancing medical technologies.

Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a leading global medical technology company known for its innovative healthcare solutions. BD's microneedle technology is focused on improving drug delivery systems, providing minimally invasive and painless ways to deliver vaccines and drugs. This is in line with BD's mission to improve patient care and advance the field of medicine with the latest technologies and products.

Other companies include Zosano Pharma Corporation, Raphas Co. Ltd., and NanoPass Technologies Ltd., among others.

Reasons to Purchase this Report

The global microneedles for drug delivery patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: Revealing the market leaders, partners and innovators helps to identify which companies have important patents in this field of Microneedles for Drug Delivery. This helps stakeholders identify the key players that shape the industry and predict future market dynamics.

• Innovation Insights: The patent applications show R&Ds ongoing efforts. Their analysis reveals new innovations and technologies in Microneedles for Drug Delivery. This helps stakeholders stay aware and alert of advancements and potential disruptions.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as Microneedles for Drug Delivery, risks of patent infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

• Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

Key Questions Answered in the Global Microneedles for Drug Delivery Patent Landscape Report

• Who are the key players in the microneedles for drug delivery patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in microneedles for drug delivery patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in microneedles for drug delivery industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in microneedles for drug delivery?
• What are the challenges and opportunities in the microneedles for drug delivery patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in microneedles for drug delivery?

Related Reports

Global Connected Drug Delivery Devices Market

Global Pulmonary Drug Delivery Systems Market

Global Controlled Release Drug Delivery Market

Global Huber Needle Market

Global Pen Needle Market